Investigating the Utility of Augmented Reality Assistance for Ultrasound-Guided Vascular Access

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age5+
SponsorUniversity of Alabama at Birmingham

About this trial

This study will investigate the benefits of augmented reality assistance on ultrasound-guided vascular access. Using the Microsoft HoloLens 2 headset, the investigators will study the benefits of augmented reality technology as a tool for improving the success rate, efficiency, and ease of access for peripheral venous catheters, peripherally inserted central venous catheters, and central venous catheters.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Patient requiring ultrasound-guided vascular access

Disqualifiers

Age less than 5 years old

Need for urgent vascular access

Trial design

Design model

Single group

Treatments tested in this trial

  • Augmented reality headset use

    Other intervention

    Use of a Microsoft HoloLens 2 headset with augmented reality assistance

Treatment groups

50 Participants
are divided into 2 treatment groups
Group A: Control ArmNo intervention 0 interventions
Group B: AR ArmExperimental treatment 1 intervention

Trial outcomes

Primary outcomes

1

Successful vascular access as indicated by blood return from the blood vessel and advancement of guide wire

Time frame
Up to 30 minutes

Secondary outcomes

1

Number of needle sticks required for successful vascular access

Time frame
Up to 30 minutes
2

Time required for successful vascular access

Time frame
Up to 30 minutes

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.